Circle Pharma
South San Francisco, US · Founded 2012 · Delaware corporation · 8 known investors
Circle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies. The company serves cancer patients and their caregivers globally.
Founders & leadership
Circle Pharma was founded in 2012 by Matthew P. Jacobson, Scott R. Lokey, and Matthew Jacobson.
MP
Matthew P. JacobsonCo-founder
SR
Scott R. LokeyCo-founder
MJ
Matthew JacobsonCo-founder
DJ
David J. EarpPresident & CEO
PP
Paul ParkExecutive
Board
WH
JE
DC
WM
SK
Stephen KelseyBoard director
JJ
John JoseyBoard director
Investors · 8
Berkeley CatalystBerkeley
Lifeforce CapitalChevy Chase · $500K – $5M
Mission Bay CapitalSan Francisco
Mission BiocapitalSan Francisco · $500K
Nextech InvestZurich · $648K – $3.2M
Pandect BioventuresWoodsidevia Walter H. Moos · board
The Column GroupSan Francisco · $30Mvia Peter Svennilson · board
WI Harper GroupSan Francisco · $5M – $15M
Reported raises · per SEC filings
Form D private placements$177.6M disclosed across 4 rounds · 2016–2024
▶$92.4MraisedJan 2025 · 14 investors · OtherRule 506(b)
▶$92.4MraisedJan 2025 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Thilo SchroederDirector
- Stephen KelseyDirector
- David J. EarpExecutive Officer, Director
- Matthew P. JacobsonDirector
- Walter H. MoosDirector
- Paul ParkExecutive Officer
- James EvangelistaDirector
- John JoseyDirector
- Offering amount
- $117.4M
- Amount sold
- $92.4M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$66.3MraisedMar 2022 · 20 investors · PharmaceuticalsRule 506(b)
▶$66.3MraisedMar 2022 · 20 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- James EvangelistaDirector
- Thilo SchroederDirector
- John JoseyDirector
- Matthew JacobsonDirector
- Elton SatuskyExecutive Officer
- David EarpExecutive Officer, Director
- Walter MoosDirector
- Offering amount
- $66.3M
- Amount sold
- $66.3M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedMar 2020 · 7 investors · OtherRule 506(b)
▶$15MraisedMar 2020 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- David J. EarpExecutive Officer, Director
- Elton SatuskyExecutive Officer
- Matthew P. JacobsonDirector
- John JoseyDirector
- Thilo SchroederDirector
- Peter SvennilsonDirector
- Cayla McEwenExecutive Officer
- Walter MoosDirector
- Offering amount
- $45M
- Amount sold
- $15M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.8MraisedSep 2016 · 4 investors · PharmaceuticalsRule 506(b)
▶$3.8MraisedSep 2016 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Scott R. LokeyDirector
- David J. EarpExecutive Officer, Director
- Douglas CrawfordDirector
- Walter MoosDirector
- Matthew JacobsonDirector
- Offering amount
- $6M
- Amount sold
- $3.8M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Collegium Pharmaceutical22 shared keywordsCollegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions. It serves patients living with serious medical conditions and the healthcare professionals caring for them.
Radiuspharm21 shared keywordsRadius is a biopharmaceutical company focused on bone health and related therapeutic areas for underserved patient populations. It markets commercial products in the U.S., including TYMLOS (abaloparatide) injection and BINOSTO (alendronate sodium).
Kite Pharma20 shared keywordsKite Pharma develops CAR T-cell therapies for cancer patients, engineering the immune system's cells to target and attack cancer. Each therapy is individualized per patient through a multi-step manufacturing process.
Companies competing with Circle Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Circle Pharma do?
- Circle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies. The company serves cancer patients and their caregivers globally.
- Who founded Circle Pharma?
- Circle Pharma was founded by Matthew P. Jacobson, Scott R. Lokey, Matthew Jacobson in 2012.
- Who are Circle Pharma's investors?
- Circle Pharma's investors include Berkeley Catalyst, Lifeforce Capital, Mission Bay Capital, Mission Biocapital, Nextech Invest, Pandect Bioventures, The Column Group, WI Harper Group.
- How much funding has Circle Pharma raised?
- Circle Pharma has disclosed $177.6M raised across 4 rounds.
- Where is Circle Pharma headquartered?
- Circle Pharma is headquartered in South San Francisco, US.